ABPDU - Advanced Biofuels Process Demonstration Unit
Lawrence Berkeley National Lab opened its Advanced Biofuels Process Demonstration Unit on Aug. 18, 2011.
SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Lawrence Berkeley National Lab opened its Advanced Biofuels Process Demonstration Unit on Aug. 18, 2011.
In this project, the ABPDU team at LBNL was going to perform scale-up and process development of Microvi’s butanol process that has been established at the shake-flask level. The ABPDU team was to perform tech transfer of analytical, and fermentation protocols that the client’s team has developed thus far. The ABPDU team was also going to perform data analysis and mass balances to author a final report. However, the project never proceeded beyond the initial planning stages, and experimental materials were not available for the ABPDU team to begin tech transfer or data analysis.
The purpose of the CRADA between Sandia National Laboratories (Sandia), Lawrence Berkeley National Laboratory (LBNL), and HelioBioSys, Inc. (HBS) was to generate a resilient cyanobacterial community for the purpose of low cost polysaccharide production from outdoor cultivation. Sandia conducted algae culturing at benchscale and in pilot scale open raceways at the Algae Testbed facility in the Sandia-California (SNL-CA) Open Campus in Livermore with monitoring of changes in the cyanobaceterial community structure based on variation in growth conditions. LBNL provided capabilities for separating sugars that are excreted from the cyanobacterial cells on-site in Livermore, and performed bench scale conversion testing at the LBNL Advanced Biofuels Process Development Unit (ABPDU). The combination of pilot scale algae culturing at Sandia and conversion testing at the state-of-the-art ABPDU facility provided HelioBioSys, Inc. with initial data for de-risking deployment of outdoor production.
Researchers at the LBNL Advanced Biofuels Process Development Unit (ABPDU) engaged in a collaborative research agreement with Allied Microbiota, to demonstrate improved cultivation of thermophilic organisms known to secrete thermally stable enzymes suitable for bioremediation applications. During the course of the project, ABPDU researchers demonstrated a fed batch bioreactor cultivation method that improved process intensity and process consistency, helping to reduce the production cost of these promising enzymes.
Through DOE’s Bioenergy Technologies Office Industrial Seeding Program and the Energy Efficiency and Renewable Energy Small Business Voucher Program, Massachusetts-based Kalion received support to work with the ABPDU to reach full manufacturing-scale production of biobased glucaric acid. One of the “Top Value-Added Chemicals from Biomass” identified in a 2004 report, glucaric acid is most commonly found in detergents and can be a substitute for less environmentally friendly phosphates. Scaling up manufacturing processes is a common obstacle for small companies like Kalion. By working with the ABPDU, Kalion went from a 2-liter to a 300-liter run via fermentation and provided another point of validation to its investors.
The objective of this study was to demonstrate feasibility and scale-up of cellulosic feedstocks for the production of a commercial C6 lactone. Visolis, Inc. has developed a fermentation platform for production of the lactone at high titers and yields. The lactone is used in high-end cosmetics industry and also serves as a valuable intermediate for production of biopolymers and biofuels. Strains employed by Visolis are capable of metabolizing both glucose and xylose, enabling full utilization of cellulosic hydrolysates as feedstock. Visolis and ABPDU conducted a 2L proof-of-concept fermentation campaign followed by a 50L scale-up campaign.
The goal of this work is to use the large fermentation vessels in the National Renewable Energy Laboratory's (NREL) Integrated Biorefinery Research Facility (IBRF) to scale-up Lygos' biological-based process for producing malonic acid and to generate performance data. Initially, work at the 1 L scale validated successful transfer of Lygos' fermentation protocols to NREL using a glucose substrate. Outside of the scope of the CRADA with NREL, Lygos tested their process on lignocellulosic sugars produced by NREL at Lawrence Berkeley National Laboratory's (LBNL) Advanced Biofuels Process Development Unit (ABPDU). NREL produced these cellulosic sugar solutions from corn stover using a separate cellulose/hemicellulose process configuration. Finally, NREL performed fermentations using glucose in large fermentors (1,500- and 9,000-L vessels) to intermediate product and to demonstrate successful performance of Lygos' technology at larger scales.
The objective of this study was to demonstrate feasibility and scale-up of cellulosic feedstocks for the production of a commercial C 6 lactone. Visolis, Inc. has developed a fermentation platform for production of the lactone at high titers and yields. The lactone is used in high-end cosmetics industry and also serves as a valuable intermediate for production of biopolymers and biofuels. Strains employed by Visolis are capable of metabolizing both glucose and xylose, enabling full utilization of cellulosic hydrolysates as feedstock. Visolis and ABPDU conducted a 2L proof-of-concept fermentation campaign followed by a 50L scale-up campaign.
In collaboration with Visolis, ABPDU researchers have demonstrated a viable path for conversion of cellulosic feedstocks into renewable precursors for commodity fuels and chemicals. This process was demonstrated with equal success for both glucose and xylose conversion. Following proof of concept in 2L bioreactors, the process was scaled and demonstrated in a 50L bioreactor.
In collaboration with Checkerspot, Inc, researchers at ABPDU have successfully demonstrated production of algal lipids at high rate, titer, and yield in fed-batch fermentation. This technology enables high-intensity fermentation of sugars to algal oil, helping to reduce the cost of algal oils as a highly customizable feedstock for development of new bio-based polyurethanes.
Through DOE’s Bioenergy Technologies Office and the Energy Efficiency and Renewable Energy Small Business Voucher (SBV) Pilot, ZymoChem, Inc received support to work with the ABPDU to accelerate the development of a novel adipic acid (AA) bioprocess by evaluating technologies to demonstrate the following: 1) Process development of AA via ZymoChem’s carbon-conserving (C 2 ) pathway in 2L bioreactors, using industrial feedstocks, and as a salt with hexamethylenediamine (HMDA), i.e., the industrially desired form of AA as AA-HMDA is the precursor for nylon 6,6 synthesis. 2) Pilot scale aerobic fermentation at the 300 L scale (stage 1) followed by a high cell density (HCD) anaerobic resting cell biotransformation (RCB) at the 50 L scale (stage 2). 3) Demonstration of a viable recovery process at the 50 L scale for purifying the product (i.e., AA-HMDA salt) and deliver multiple kg-quantity batches of purified product for further testing.
In collaboration with Aequor, Inc, ABPDU researchers have evaluated a number of antibiofouling compounds for biofilm reduction potential in biomanufacturing applications. In addition to verifying their efficacy as dispersants, studies with bacteria, fungi, and algae indicate compatibility with canonical industrial host organisms. In addition, these molecules were found to significantly enhance growth rates of heterotrophic algae, indicating potential applications in algal cultivations.
CinderBio’s vision is to harness three billion years of biology to transform many industrial practices into sustainable processes with superior performance. Environments such as volcanic hot springs have evolved extremophilic microbes and enzymes that are naturally heat and acid stable. CinderBio was founded based on technologies developed at Lawrence Berkeley National Laboratory. Our core technologies are the molecular tools and know how to efficiently express extremophilic genes in an extremophilic host such that they retain their natural heat and acid stability. During this project, we tested our enzymes at the Advanced Biofuels and Bioproducts Process Development Unit (ABPDU), automated our fermentation and downstream processing, and built a comprehensive technoeconomic assessment (TEA) model for our manufacturing costs.
This project successfully developed an innovative, cost-effective, and scalable method for converting low-cost agricultural waste feedstocks into nanocellulose—a sustainable material with wide-ranging industrial applications. It addressed the critical challenges of high production costs and limited global supply, which have hindered the widespread adoption of nanocellulose in industry. Through this work, significant advancements were made in optimizing resource use, improving process efficiency, and reducing costs. Notable achievements included a 50% reduction in water usage, 30% lower chemical consumption, and 20% energy savings, all while maintaining high-quality product standards. The technical feasibility of the process was further validated at a 10L scale in collaboration with the Advanced Biofuels and Bioproducts Development Unit (ABPDU), demonstrating scalability and replicability. Key challenges in reducing nanocellulose production costs were addressed by utilizing low-cost biomass feedstocks and implementing low-temperature conversion reactions, leading to lower capital and operating expenses. The project also mitigated financial risk by generating critical data on the feasibility, adaptability, and scalability of the conversion technology, paving the way for its commercial implementation. Public benefits include advancing the circular bioeconomy, reducing environmental impact, fostering job creation, and enabling a shift toward biobased materials as sustainable alternatives to fossil-based products. These outcomes align closely with national goals to reduce greenhouse gas emissions and promote sustainable technological innovation.
ABPDU staff worked with Teselagen to provide expertise and perform literature searches for therapeutic carrying strains to maximize fermentation parameters for Teselagen's machine learning platform. The goal was to overcome the COVID-19 crisis and plan for a future where molecules can be detected, diagnosed, built, manufactured, and distributed within months.
In this project, a genetically modified Saccharomyces cerevisiae was used to produce Histamine via fermentation of dextrose. Zymergen provided a tech transfer document based on their 1 L studies, where they observed a titer of 0.9 g/L with this strain. The ABPDU staff performed two bench scale campaigns, with four 2 L reactors in each campaign, to carry out tech transfer and process optimization studies. Optimization was pursued by varying initial glucose concentration, feed initiation conditions, feed strategies, vitamin supplementation, inoculum size, etc. We chose a 2 L process condition, with 4% inoculum volume, continuous feed initiated after complete ethanol depletion, that yielded the most promising titers (2.41 g/L) for scale up to 300 L.
Low-boiling alkylamines such as butylamine offer promise as effective biomass pretreatment solvents that can be readily recovered and recycled; however, their capability to support microbial conversion of nutrients present in hydrolysates represents an important area for investigation. Here we employed butylamine to pretreat poplar biomass and characterize its effects on the release of fermentable sugars after solvent removal and enzymatic hydrolysis, as well as the biocompatibility of the produced hydrolysates with three organisms commonly used as bioconversion hosts. We observed that residual butylamine and the derivative butylacetamide were present in high enough concentrations to exert toxicity to strains of Aspergillus niger, Pseudomonas putida, and Rhodosporidium toruloides that produce malic acid, isoprenol and bisabolene, respectively. Removal of the toxic compounds by charcoal filtration and nutrient supplementation resulted in a hydrolysate containing >100 g L −1 of sugars that enabled strong growth, substrate consumption and bioproduct accumulation, outperforming defined cultivation media. This is the first demonstration of a butylamine-based deconstruction process for poplar biomass at a pilot-scale to achieve conversion of high sugar concentrations to valuable bioproducts with engineered microbes.